• Return to Headlines

Shares of Dexcom Rise to a New 52-Week High

By Shiri Gupta

Dexcom (NASDAQ:DXCM) traded today at a new 52-week high of $174.28. Approximately 82,000 shares have changed hands today, as compared to an average 30-day volume of 889,000 shares.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

In the past 52 weeks, shares of Dexcom have traded between a low of $85.76 and a high of $174.28 and are now at $174.28, which is 103% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.4% while the 200-day MA has risen 0.4%.

Dexcom (NASDAQ:DXCM) is currently priced 53.4% above its average consensus analyst price target of $81.25. The stock should find initial support at its 50-day moving average (MA) of $151.61 and further support at its 200-day MA of $135.36.

SmarTrend is monitoring the recent change of momentum in Dexcom. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Dexcom in search of a potential trend change.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM